植入心脏起器后的左心室功能障碍:谁可以从前置传导系统节奏中受益?
Jordi Lozano-Torres1, Eduard Ródenas-Alesina1, Jaume Francisco-Pascual2
1Cardiology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institut de Recerca, Barcelona; Medicine Department, Universitat Autònoma de Barcelona, Barcelona; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBER-CV), Madrid, Spain.
Heart rhythm
|November 2, 2025
概括
节奏诱导心肌病 (PICM) 是植入心脏起器后的一种风险. 一个新的风险评分可以预测PICM的严重程度,并指导预防性节奏策略,改善患者的结果.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医疗器械技术 医疗器械技术
背景情况:
- 节奏诱导心肌病 (PICM) 是已知的心脏起器植入的并发症.
- PICM与较差的患者预后和不良心血管事件有关.
研究的目的:
- 通过使用各种定义来评估PICM的发病率和预后影响.
- 开发一种植入前风险评分,用于预测PICM严重程度和相关不良事件.
主要方法:
- 对678名经过心脏起器植入的患者进行了回顾性分析.
- 利用了五种基于文献的定义来进行PICM诊断,并分析了心血管死亡或心力衰竭住院治疗作为综合终点.
- 开发并验证了多变量后勤回归风险评分,其中包含了植入前参数.
主要成果:
- 根据使用的定义,PICM发生率从5.0%到19.6%不等.
- PICM显著增加了复合终点 (HR 3.23-5.23) 的风险,严重程度与结果相关.
- 开发的风险评分显示了PICM和不良事件的良好预测准确性 (AUC 0.710).
结论:
- 更严格的PICM定义可以识别高风险的患者子组.
- 经验证的风险评分可以预测PICM的发生,并告知使用预防性导电系统步调.
- 风险分层可以优化心脏起器植入的决策,潜在地防止过度治疗和改善结果.
相关概念视频
Cardiomyopathy V: Interprofessional Care
326
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
326
Cardiomyopathy II: Dilated Cardiomyopathy
455
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
455
Cardiomyopathy III: Hypertrophic Cardiomyopathy
387
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
387
Cardiomyopathy VII: Pre and Post Operative Nursing Management
274
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
274
Conduction System of the Heart
12.4K
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
12.4K
Conduction System of the Heart
3.3K
The cardiac conduction system produces and transmits electrical impulses that prompt myocardial contraction, ensuring efficient heart function. This intricate system ensures that the heart beats in a coordinated and efficient manner, beginning with the atria and then the ventricles. The conduction system optimizes cardiac output by maintaining this precise sequence, which is crucial for adequate blood circulation.
This system relies on the unique properties of nodal and Purkinje cells:...
This system relies on the unique properties of nodal and Purkinje cells:...
3.3K


